InvestorsHub Logo
Followers 4
Posts 175
Boards Moderated 0
Alias Born 11/12/2013

Re: None

Sunday, 02/01/2015 11:50:01 PM

Sunday, February 01, 2015 11:50:01 PM

Post# of 48316
This Phase II clinical trial will be conducted as a multicenter Investigator Sponsored Trial (IST), with UCSF and Dr. Alain Algazi as the sponsor. Merck will supply pembrolizumab, and OncoSec will provide electroporation devices and plasmid IL-12. Enrollment is expected to begin in Q1 2015.